+328.9%
CME vs THC
+1,421.6%
-1,092.8%
-37.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.4% | -1.1% | +0.7% | -0.3% |
| 7D | +0.9% | +3.7% | -2.8% | +0.6% |
| 30D | +13.2% | +9.0% | +4.1% | +12.3% |
| 3M | +16.3% | +10.4% | +5.9% | +15.2% |
| 6M | +7.1% | +45.7% | -38.5% | +3.4% |
| YTD | +15.8% | +42.6% | -26.7% | +11.6% |
| 1Y | +17.1% | +38.8% | -21.7% | +13.0% |
| 3Y | +63.2% | +418.8% | -355.7% | +37.0% |
| 5Y | +70.2% | +275.7% | -205.5% | +44.3% |
| All | +328.9% | +1,421.6% | -1,092.8% | +214.9% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling